Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GS-9667, a selective and partial agonist of the A(1) adenosine receptor (AR), represents an effective therapy for Type 2 diabetes (T2DM) and dyslipidemia via lowering of free fatty acids (FFA).
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 30,500 | |||
5 mg | 在庫あり | ¥ 73,500 | |||
10 mg | 在庫あり | ¥ 108,000 | |||
25 mg | 在庫あり | ¥ 177,500 | |||
50 mg | 在庫あり | ¥ 248,000 | |||
100 mg | 在庫あり | ¥ 335,000 | |||
500 mg | 在庫あり | ¥ 670,500 |
説明 | GS-9667, a selective and partial agonist of the A(1) adenosine receptor (AR), represents an effective therapy for Type 2 diabetes (T2DM) and dyslipidemia via lowering of free fatty acids (FFA). |
別名 | CVT-3619, CVT 3619 |
分子量 | 461.51 |
分子式 | C21H24FN5O4S |
CAS No. | 618380-90-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (119.17 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GS-9667 618380-90-8 GPCR/G Protein Neuroscience Adenosine Receptor CVT3619 CVT-3619 CVT 3619 GS9667 GS 9667 Inhibitor inhibitor inhibit